Details for Patent: 11,278,683

Which drugs does patent 11,278,683 protect, and when does it expire?

Patent 11,278,683 protects LONHALA MAGNAIR KIT and is included in one NDA.

This patent has fourteen patent family members in ten countries.

Summary for Patent: 11,278,683

Title:	Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized
Abstract:	An inhalation therapy device includes an atomizer for atomizing a drug which is advantageously present in the form of a fluid into an atomization chamber so that an aerosol or mist is provided in the atomization chamber. The patient or user can inhale the aerosol produced by the atomizer from the atomization chamber via a mouthpiece. The ampoule is inserted into an ampoule holder holding the fluid-containing ampoule. The inhalation therapy device also includes an opening unit for opening the fluid-containing ampoule. The ampoule holder advantageously includes a first part, disposed displaceably in relation to the opening unit, thereby allowing an ampoule present in the ampoule holder to be displaced in the direction of the opening unit.
Inventor(s):	Uwe Hetzer, Thomas Gallem
Assignee:	PARI Pharma GmbH
Application Number:	US15/716,756
Patent Claim Types: see list of patent claims	Device;

Drugs Protected by US Patent 11,278,683

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sumitomo Pharma Am	LONHALA MAGNAIR KIT	glycopyrrolate	SOLUTION;INHALATION	208437-001	Dec 5, 2017		DISCN	Yes	No			Y

Foreign Priority and PCT Information for Patent: 11,278,683

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	10 2005 038 619.9	Aug 16, 2005

International Family Members for US Patent 11,278,683

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006281561
Brazil	PI0614818
Canada	2619605
China	101291699